June 6, 2023

Avian Influenza Elisa

Lab Reagents

Human IgG antibody Laboratories manufactures the avian influenza elisa reagents distributed by Genprice. The Avian Influenza Elisa reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza elisa. Other Avian products are available in stock. Specificity: Avian Category: Influenza Group: Elisa

Elisa information

Avian Influenza Hemagglutinin 1 Peptide

3925P 0.05 mg
EUR 197.7
Description: (IN) Avian Influenza Hemagglutinin 1 peptide

Avian Influenza Hemagglutinin 2 Antibody

24449-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin 3 Antibody

24450-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin 4 Antibody

24451-100ul 100ul
EUR 468

Avian Influenza Hemagglutinin 1 Antibody

24454-100ul 100ul
EUR 468

Avian Influenza A M2 Antibody

24577-100ul 100ul
EUR 468

Influenza A H5N1 Avian Antibody

abx021960-100ug 100 ug
EUR 1011.6

Influenza A H5N1 Avian Antibody

abx021961-100ug 100 ug
EUR 1011.6

Influenza A H5N1 Avian Antibody

abx023061-100ug 100 ug
EUR 961.2

Influenza A H5N1 Avian Antibody

abx023062-100ug 100 ug
EUR 828

Influenza A H5N1 Avian Antibody

abx023064-100ug 100 ug
EUR 961.2

Polyclonal Avian Influenza Neuraminidase Antibody

APR11000G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza Neuraminidase . This antibody is tested and proven to work in the following applications:

Polyclonal Avian Influenza Neuraminidase Antibody

APR11001G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Avian Influenza Neuraminidase . This antibody is tested and proven to work in the following applications:

Avian influenza H5N8 PCR kit

PCR-V063-48R 50T
EUR 987.6

Avian influenza H5N8 PCR kit

PCR-V063-96R 100T
EUR 1335.6

Avian Influenza H5N1 Hemagglutinin (NT) Antibody

3909-002mg 0.02 mg
EUR 206.18
Description: Avian Influenza Hemagglutinin 2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.

Avian Influenza H5N1 Hemagglutinin (NT) Antibody

3909-01mg 0.1 mg
EUR 523.7
Description: Avian Influenza Hemagglutinin 2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability.